GemPharmatech Balance Sheet Health
Financial Health criteria checks 6/6
GemPharmatech has a total shareholder equity of CN¥2.1B and total debt of CN¥68.1M, which brings its debt-to-equity ratio to 3.2%. Its total assets and total liabilities are CN¥2.5B and CN¥410.2M respectively. GemPharmatech's EBIT is CN¥95.1M making its interest coverage ratio -4.6. It has cash and short-term investments of CN¥1.2B.
Key information
3.2%
Debt to equity ratio
CN¥68.09m
Debt
| Interest coverage ratio | -4.6x |
| Cash | CN¥1.21b |
| Equity | CN¥2.12b |
| Total liabilities | CN¥410.23m |
| Total assets | CN¥2.53b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 688046's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥341.4M).
Long Term Liabilities: 688046's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥68.8M).
Debt to Equity History and Analysis
Debt Level: 688046 has more cash than its total debt.
Reducing Debt: 688046's debt to equity ratio has reduced from 5% to 3.2% over the past 5 years.
Debt Coverage: 688046's debt is well covered by operating cash flow (93.3%).
Interest Coverage: 688046 earns more interest than it pays, so coverage of interest payments is not a concern.